The element actinium was first discovered at the turn of the 20th century, but even now, nearly 125 years later, researchers still don’t have a good grasp on the metal’s chemistry. That’s because actinium is only available in extremely small amounts and working with the radioactive material requires special facilities. But to improve emerging cancer treatments using actinium, researchers will need to better understand how the element binds with other molecules.
In a study led by the Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab), researchers grew crystals containing actinium and studied the compound’s atomic structure. While elements often behave similarly to their lighter cousins on the periodic table, researchers were surprised to find that the actinium behaved differently than predicted by looking at its counterpart, lanthanum.
“There’s a breadth of applications for these elements, from nuclear energy to medicine to national security, but if we don’t know how they behave, that inhibits the progress we can make,” said Jen Wacker, first author of the paper published in Nature Communications and a chemist at Berkeley Lab.
“We’re seeing that this work is necessary to really understand the complexity of these radioactive elements, because in a lot of cases, using their surrogates is not sufficient to understand their chemistry.”
One area of interest is in using an isotope of actinium (actinium-225) in a cancer treatment method called targeted alpha therapy (TAT), which has shown promise in clinical trials. The TAT method uses biological delivery systems such as peptides or antibodies to move the radioactive element to the cancer site.
When the actinium decays, it releases energetic particles that travel a short distance, destroying the nearby cancer cells but sparing healthy tissue further away.

“There’s a movement to design better delivery systems to get the actinium to particular cells and keep it there,” said Rebecca Abergel, a UC Berkeley associate professor of nuclear engineering and of chemistry who leads the Heavy Element Chemistry Group at Berkeley Lab.
“If we can engineer proteins to bind the actinium with a really high affinity, and either be fused with an antibody or serve as the targeting protein, that would really enable new ways to develop radiopharmaceuticals.”
Researchers used a novel approach to grow the crystals using only 5 micrograms of pure actinium—roughly one tenth the weight of a grain of salt, and invisible to the naked eye. They first purified the actinium through a complex filtration process that removed other elements and chemical impurities.
They then bound the actinium to a metal-trapping molecule called a ligand and enveloped the bundle inside of a protein isolated and purified by Roland Strong’s team at the Fred Hutchinson Cancer Center, building a “macromolecular scaffold.”
The crystals, grown over a week inside of the Heavy Element Research Laboratory, were then cryocooled in liquid nitrogen and illuminated with X-rays at Berkeley Lab’s Advanced Light Source (ALS). The X-rays revealed the compound’s 3D structure and showed how actinium interacted with surrounding atoms. It is the first single-crystal X-ray structure reported for actinium
“I’ve been working in crystallography for 40 years and seen a lot of things, and the method the team is using is unique and provides details we couldn’t get in the past,” said Marc Allaire, a scientist in Berkeley Lab’s Molecular Biophysics and Integrated Bioimaging Division and head of the Berkeley Center for Structural Biology team at the ALS.
“To the best of my knowledge, Berkeley Lab is the only place in the world where we do this kind of study and measure radioactive protein crystals.”
-
Joshua Woods and Appie Peterson measure a small sample of actinium. Credit: Marilyn Sargent/Berkeley Lab -
This rendering shows the structure of how actinium (magenta) binds with other molecules. Red triangles point out how the arrangement differs from actinium’s lighter counterpart, lanthanum (gray). The stick structure of the binding molecule (the ligand) is surrounded by pockets in the protein. Credit: Jen Wacker/Berkeley Lab
In this work, scientists used actinium-227, the longest-lived isotope of the element. Future studies will explore actinium-225 (the preferred isotope for targeted alpha therapy) to look for other changes in how the metal binds. Researchers are also interested in pairing actinium with different proteins to learn more about the structures it forms.
“This is very fundamental science that is part of our core program in understanding the chemistry of heavy elements,” Abergel said.
“We’ve achieved a really technically difficult experimental method that pushes the boundaries of isotope chemistry and lets us gain a better understanding of this element. It hopefully will enable us and others to develop better systems that are useful for targeted alpha therapy.”
More information: Jennifer N. Wacker et al, Actinium chelation and crystallization in a macromolecular scaffold, Nature Communications (2024). DOI: 10.1038/s41467-024-50017-5
Journal information: Nature Communications
Provided by Lawrence Berkeley National Laboratory
News
An Ancient Virus May Hold the Secret to What Makes the Human Brain Different
Could a virus that infected chimpanzees millions of years ago help explain how the human brain became different? Researchers at Lund University have discovered that ancient viral DNA embedded in the chimpanzee genome silences [...]
Could a Nasal Spray Stop Alzheimer’s Before Memory Loss Begins?
Protecting memory from Alzheimer’s may one day involve a nasal spray, with encouraging results in animals and evidence that its particles also protect human neurons grown in the lab. Alzheimer’s disease damages the connections [...]
A sceptical guide to AI agents in drug discovery
In conversation with Dr Eric Ma, Senior Principal Data Scientist at Moderna, Dr Raminderpal Singh examines what AI agents are actually good for, where the lock-in hides and why expertise has become more valuable [...]
Study identifies new targets for antiviral drugs against coronaviruses
A study led by researchers at the University of California San Diego School of Medicine and University of California, Riverside (UCR) School of Medicine has identified new targets for antiviral drugs against coronaviruses, including [...]
“Nearly Everybody Had Given Up” – Scientists Finally Solve a 60-Year Chemistry Mystery
After more than six decades of failed attempts, chemists have achieved a breakthrough involving a class of molecules long considered too unstable to isolate. Chemists have succeeded in isolating a group of molecules that [...]
Depression Symptoms Improved in Just 48 Hours After a Single Psychedelic Dose
A single dose of psilocybin produced rapid antidepressant effects in a small Swedish clinical trial, with improvements lasting for weeks. A single dose of psilocybin, the psychedelic compound found in magic mushrooms, produced rapid [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Human Bodies Are Producing Two Billion Tons of CO2 a Year
A new study reveals that the amount of carbon dioxide produced by human metabolism has increased dramatically over three decades. The carbon dioxide produced by human bodies as they convert food into energy increased [...]
A Hidden DNA Mechanism Could Explain How 20% of Human Cancers Develop
Researchers have identified an unexpected molecular vulnerability in cancers carrying BAF mutations. Mutations found in roughly 20% of human cancers may promote tumor growth by changing how DNA is organized inside cells. Researchers have [...]
Ebola kills over 5,300 in fastest-growing outbreak on record
Africa’s latest Ebola outbreak has killed nearly 5,400 people, the vast majority of them in the Democratic Republic of Congo (DRC), according to the continent’s top health agency. Africa Centres for Disease Control and [...]
China makes early progress in using sound waves to stimulate damaged brains
Chinese researchers are testing whether focused ultrasound can help restore consciousness in patients with severe brain injuries, adding to a growing international effort to use sound waves to stimulate deep brain structures without surgery. [...]
Micro-drones fly through the body thanks to ultrasound
At the EPFL, micro-drones have been developed that can be moved without a motor or battery.No motors, no batteries, no electronics on board, just small cavities that convert sound waves into thrust: this is [...]
A Single Enzyme Could Hold the Key to Treating a Devastating Brain Disorder
Blocking an enzyme’s production restored brain growth and healthy behaviors in mice engineered to develop Angelman syndrome, pointing to a possible treatment target. Children with Angelman syndrome begin to show difficulties with thinking and [...]
Scientists Develop a Clever New Way To Kill Cancer Cells From the Inside
Scientists have developed an experimental strategy that exploits a chemical byproduct of cancer cells to produce anticancer drugs directly inside them. Scientists in Japan have developed an experimental method that uses a chemical produced [...]
Our books are available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
After only a short training, people in a coma managed to send targeted signals
Researchers have succeeded in communicating with brain-injured patients who are unconscious. They see enormous potential in this for future treatments. Patients who lie motionless in bed after a severe brain injury and do not [...]

















